PFE
WAITPfizer, Inc.
$25.15
-0.40%delayed
News – · Trend ▲ · inside triggers –
Expected move (1d)
▼ $24.64to$25.66 ▲
ATR ±$0.51 (+2.02%)Implied ±$0.42 (+1.65%)
Entry Reference
Price / prev close$25.15 / $25.25
Day range$25.06 – $25.37
52-wk range$23.11 – $28.75(36%)
Volume vs avg0.64×
ATR (14d)$0.51
MA 8 / 21$24.89 / $24.54
MA 50 / 200$25.11 / $25.83
Call ▲ / Put ▼ trigger$25.37 / $25.13
+1 / +2 ATR$25.66 / $26.16
-1 / -2 ATR$24.64 / $24.14
Support: 24.57 23.62
Resistance: 25.19 25.65 26.20
Near-the-money contracts
exp 2026-07-31Calls
| Strike | Mark | IV | Δ | θ/day | OI |
|---|---|---|---|---|---|
| 24 | $0.91 | 52% | 0.90 | -0.05 | 2646 |
| 24.5 | $0.71 | 46% | 0.80 | -0.07 | 1446 |
| 25 | $0.30 | 27% | 0.63 | -0.05 | 15870 |
| 25.5 | $0.08 | 24% | 0.21 | -0.04 | 12647 |
| 26 | $0.01 | 26% | 0.03 | -0.01 | 9359 |
| 26.5 | $0.01 | 31% | 0.01 | -0.00 | 2084 |
Puts
| Strike | Mark | IV | Δ | θ/day | OI |
|---|---|---|---|---|---|
| 24 | $0.01 | 30% | -0.01 | -0.00 | 36560 |
| 24.5 | $0.03 | 24% | -0.05 | -0.01 | 8028 |
| 25 | $0.12 | 22% | -0.34 | -0.04 | 2946 |
| 25.5 | $0.42 | 29% | -0.74 | -0.04 | 259 |
| 26 | $0.82 | 35% | -0.91 | -0.02 | 423 |
| 26.5 | $1.32 | 183% | -0.63 | -0.34 | 4 |
Δ = delta (≈ probability ITM), θ/day = daily time decay, IV = implied vol. Greeks computed via Black-Scholes from Yahoo IV.
Recent news
- The Real Price of AbbVie Stock Is Cheaper Than You Think3h ago
- Moderna Q2 Earnings Loom: Buy or Sell the Stock Ahead of Results?5h ago
- Pfizer Stock Ahead of Q2 Earnings: To Buy or Not to Buy?6h ago
- Eli Lilly (LLY) Earnings Expected to Grow: Should You Buy?8h ago
- 5 High-Yielding Dividend Stocks for Retirees to Buy and Hold Forever9h ago
- Freehand Raises $75M to Scale AI Teams Managing Supply Chain Spend for Fortune 500 Companies9h ago
- Boomers Are Buying 5 Quality High-Yield Stocks at Big Discounts Hand Over Fist9h ago
- Pfizer (PFE) Surpasses Market Returns: Some Facts Worth Knowing1d ago
- What Johnson & Johnson Stock Told You Before It Surged1d ago
- Does Eli Lilly Stock Actually Diversify Your Portfolio?1d ago
- 3 Major Reasons for Investors to Buy AbbVie Stock Before July 31st1d ago
- Here's How LLY's Non-GLP-1 Portfolio Is Poised Ahead of Q2 Earnings1d ago
Reference data only. Not a recommendation. Greeks and expected-move figures are estimates, not certainties. You confirm all entries and contracts in TradingView and Charles Schwab.